Sangamo Therapeutics, Inc. SGMO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sangamo Therapeutics, Inc. SGMO

SGMO 0.561

-2.3%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: bob zagorin	6/19/2008 11:24:30 AM
	of 368

Sangamo BioSciences-SGMO: Unit of DOW exercises commercial ZFP option@LEER Dow AgroSciences is exercising their option sooner than had been anticipated which is improving SGMO's financial flexibility. LEER will be watching for sublicensing royalties from DAS within a few quarters and with their expectations over the next year of further protein manufacturing emerging from SGMO, a share price of $18 is a reasonable expectation. Reiterate Outperform rating. :

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next